- Home
- ASND vs HST Comparison
ASND vs HST Comparison
Compare ASND & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- HST
- Stock Information
- Founded
- ASND 2006
- HST 1927
- Country
- ASND Denmark
- HST United States
- Employees
- ASND N/A
- HST N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- HST Real Estate Investment Trusts
- Sector
- ASND Health Care
- HST Real Estate
- Exchange
- ASND Nasdaq
- HST Nasdaq
- Market Cap
- ASND 10.6B
- HST 10.0B
- IPO Year
- ASND 2015
- HST N/A
- Fundamental
- Price
- ASND $170.14
- HST $16.60
- Analyst Decision
- ASND Strong Buy
- HST Buy
- Analyst Count
- ASND 17
- HST 14
- Target Price
- ASND $222.18
- HST $18.11
- AVG Volume (30 Days)
- ASND 412.4K
- HST 7.5M
- Earning Date
- ASND 09-02-2025
- HST 07-30-2025
- Dividend Yield
- ASND N/A
- HST 5.42%
- EPS Growth
- ASND N/A
- HST N/A
- EPS
- ASND N/A
- HST 0.96
- Revenue
- ASND $398,509,511.00
- HST $5,816,000,000.00
- Revenue This Year
- ASND $77.19
- HST $4.90
- Revenue Next Year
- ASND $75.84
- HST $1.89
- P/E Ratio
- ASND N/A
- HST $17.31
- Revenue Growth
- ASND 12.06
- HST 7.54
- 52 Week Low
- ASND $111.09
- HST $12.22
- 52 Week High
- ASND $183.00
- HST $19.37
- Technical
- Relative Strength Index (RSI)
- ASND 47.59
- HST 62.19
- Support Level
- ASND $165.24
- HST $16.06
- Resistance Level
- ASND $179.96
- HST $16.61
- Average True Range (ATR)
- ASND 6.21
- HST 0.32
- MACD
- ASND -1.07
- HST -0.00
- Stochastic Oscillator
- ASND 33.20
- HST 75.32
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.